HK1214273A1 - 經改造的 解整合素領域多肽及用法 - Google Patents
經改造的 解整合素領域多肽及用法Info
- Publication number
- HK1214273A1 HK1214273A1 HK16102056.9A HK16102056A HK1214273A1 HK 1214273 A1 HK1214273 A1 HK 1214273A1 HK 16102056 A HK16102056 A HK 16102056A HK 1214273 A1 HK1214273 A1 HK 1214273A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- adam
- modified
- domain polypeptides
- disintegrin domain
- adam disintegrin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3679—Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6489—Metalloendopeptidases (3.4.24)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30363110P | 2010-02-11 | 2010-02-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1214273A1 true HK1214273A1 (zh) | 2016-07-22 |
Family
ID=44368103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16102056.9A HK1214273A1 (zh) | 2010-02-11 | 2016-02-24 | 經改造的 解整合素領域多肽及用法 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20130045244A1 (zh) |
EP (2) | EP2910565A3 (zh) |
JP (1) | JP2013519374A (zh) |
CA (1) | CA2789679A1 (zh) |
HK (1) | HK1214273A1 (zh) |
WO (1) | WO2011100362A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101535492A (zh) | 2005-02-11 | 2009-09-16 | 南加州大学 | 表达含有二硫键的蛋白质的方法 |
US8802394B2 (en) | 2008-11-13 | 2014-08-12 | Radu O. Minea | Method of expressing proteins with disulfide bridges with enhanced yields and activity |
US20130177528A1 (en) * | 2011-11-10 | 2013-07-11 | Western University Of Health Sciences | Compositions and methods for inhibiting viral infection |
CN102433388B (zh) * | 2012-01-04 | 2013-03-20 | 河南科技大学 | 一种肝癌早期诊断试剂盒 |
CA2958906C (en) * | 2014-08-22 | 2021-05-04 | National Cheng Kung University | Disintegrin variants and pharmaceutical uses thereof |
LT3558391T (lt) | 2016-12-23 | 2022-07-11 | Immunogen, Inc. | Imunokonjugatai, kurių taikinys yra adam9, ir jų naudojimo būdai |
EP3558368A4 (en) | 2016-12-23 | 2020-12-30 | MacroGenics, Inc. | ADAM9 BINDING MOLECULES AND THEIR METHODS FOR USE |
CA3094136A1 (en) * | 2018-01-31 | 2019-08-08 | Verra Therapeutics LLC | Methods and compositions for inhibiting adam9 biological activities |
TWI831797B (zh) | 2018-06-26 | 2024-02-11 | 美商伊繆諾金公司 | 靶向adam9之免疫接合物及其使用方法 |
KR20210089699A (ko) | 2018-11-08 | 2021-07-16 | 서트로 바이오파마, 인크. | 산화성 세포질을 갖는 대장균 균주 |
CN114040769A (zh) * | 2019-06-28 | 2022-02-11 | 住友精化株式会社 | 创伤治疗用气体组合物及创伤治疗装置 |
JP2023504533A (ja) | 2019-12-05 | 2023-02-03 | ベセエネ ペプチドス エセ.ア. | 癌および/または転移の治療のためのペプチド |
US20240165256A1 (en) | 2021-03-08 | 2024-05-23 | Immunogen, Inc. | Methods for increasing efficacy of immunoconjugates targeting adam9 for the treatment of cancer |
CN114569709B (zh) * | 2022-05-05 | 2022-07-12 | 苏州慧疗生物医药科技有限公司 | 高表达adam-28的黑色素瘤自体肿瘤疫苗的制备方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19713213A1 (de) * | 1997-03-28 | 1998-10-01 | Ruebben Alexander Dr Med | Metallstent zur verlängerten Offenhaltung von Hohlorganen |
FR2827775B1 (fr) * | 2001-07-26 | 2003-09-26 | Bioalliance Pharma | Utilisation dans une composition anti-angiogenique du domaine disintegrine d'adamalysine |
US20030186334A1 (en) * | 2001-09-12 | 2003-10-02 | Temple University - Of The Commonwealth System Of Higher Education | KTS-disintegrins |
JP2004217535A (ja) * | 2003-01-10 | 2004-08-05 | Nec Soft Ltd | 蛋白質trimestatinの結晶化、構造座標の決定、構造座標の使用 |
CN101535492A (zh) | 2005-02-11 | 2009-09-16 | 南加州大学 | 表达含有二硫键的蛋白质的方法 |
WO2010093976A1 (en) * | 2009-02-12 | 2010-08-19 | University Of Southern California | Bioadhesive patch for sutureless closure of soft tissue |
-
2011
- 2011-02-09 EP EP14200166.8A patent/EP2910565A3/en not_active Withdrawn
- 2011-02-09 EP EP11742753.4A patent/EP2534171A4/en not_active Withdrawn
- 2011-02-09 JP JP2012552964A patent/JP2013519374A/ja not_active Withdrawn
- 2011-02-09 WO PCT/US2011/024243 patent/WO2011100362A1/en active Application Filing
- 2011-02-09 US US13/578,551 patent/US20130045244A1/en not_active Abandoned
- 2011-02-09 CA CA2789679A patent/CA2789679A1/en not_active Abandoned
-
2016
- 2016-02-24 HK HK16102056.9A patent/HK1214273A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2011100362A1 (en) | 2011-08-18 |
EP2910565A2 (en) | 2015-08-26 |
EP2534171A1 (en) | 2012-12-19 |
EP2910565A3 (en) | 2015-11-04 |
JP2013519374A (ja) | 2013-05-30 |
US20130045244A1 (en) | 2013-02-21 |
CA2789679A1 (en) | 2011-08-18 |
EP2534171A4 (en) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1214273A1 (zh) | 經改造的 解整合素領域多肽及用法 | |
HUS2100032I1 (hu) | Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk | |
HK1252803A1 (zh) | 5-位修飾的嘧啶及它們的用途 | |
HK1206004A1 (zh) | 巨大戟二萜醇- -酰化物 和巨大戟二萜醇- -氨基甲酸酯 | |
HK1187049A1 (zh) | 雙芳基連接的芳基三唑酮及其用途 | |
EP2655415A4 (en) | THREE VARIABLE DOMAIN LINK PROTEINS AND USES THEREOF | |
HUE044763T2 (hu) | Frekvencia- és idõtartománybeli kiterjesztés | |
EP2593403A4 (en) | MATERIALS AND APPLICATIONS THEREFOR | |
GB201012175D0 (en) | Procedure and mechanisms | |
EP2552953A4 (en) | FRIZZLED-BINDING SUBSTANCES AND ITS USES | |
EP2582836A4 (en) | PRPK-TPRKB MODULATORS AND ITS APPLICATIONS | |
EP2558137A4 (en) | METHODS AND COMBINATION | |
GB2477597B (en) | Disinfectant materials and methods | |
HRP20182083T1 (hr) | Nova kombinacija i uporaba | |
EP2563816A4 (en) | ANTI-ICAM-1 SINGLE DOMAIN ANTIBODIES AND USES THEREOF | |
EP2566513A4 (en) | MODULATION OF GFI1B AND USES THEREOF | |
EP2608785A4 (en) | LIPOMA CYCLES AND ITS USES | |
EP2529013A4 (en) | NOVEL BETA GLUCOSIDASE AND USES THEREOF | |
GB0912744D0 (en) | Methods and uses | |
IL211790A0 (en) | Time domain vibration reduction and control | |
GB201120324D0 (en) | Improved containers and assembly thereof | |
EP2531223A4 (en) | NEW METHODS AND DEVICES | |
EP2533794A4 (en) | PROTEIN DOMAINS AND ASSOCIATED USES | |
ZA201104629B (en) | Closure and closure arrangement | |
EP2638160A4 (en) | NUCLIONS AND RIBOCAPSIDES |